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SUMMARY
The type III secretion system (T3SS) and exopolysaccharide (EPS)
amylovoran are two essential pathogenicity factors in Erwinia
amylovora, the causal agent of the serious bacterial disease fire
blight. In this study, small molecules that inhibit T3SS gene expression in E. amylovora under hrp (hypersensitive response and
pathogenicity)-inducing conditions were identified and characterized using green fluorescent protein (GFP) as a reporter. These
compounds belong to salicylidene acylhydrazides and also inhibit
amylovoran production. Microarray analysis of E. amylovora
treated with compounds 3 and 9 identified a total of 588 significantly differentially expressed genes. Among them, 95 and 78
genes were activated and suppressed by both compounds, respectively, when compared with the dimethylsulphoxide (DMSO)
control. The expression of the majority of T3SS genes in
E. amylovora, including hrpL and the avrRpt2 effector gene, was
suppressed by both compounds. Compound 3 also suppressed the
expression of amylovoran precursor and biosynthesis genes.
However, both compounds induced significantly the expression of
glycogen biosynthesis genes and siderophore biosynthesis, regulatory and transport genes. Furthermore, many membrane, lipoprotein and exported protein-encoding genes were also activated
by both compounds. Similar expression patterns were observed for
compounds 1, 2 and 4. Using crab apple flower as a model,
compound 3 was capable of reducing disease development in
pistils. These results suggest a common inhibition mechanism
shared by salicylidene acylhydrazides and indicate that smallmolecule inhibitors that disable T3SS function could be explored to
control fire blight disease.

*Correspondence. Email: zhao888@illinois.edu
†Present address: Department of Plant Pathology, University of Nebraska-Lincoln, NE
68583, USA.

INTRODUCTION
Erwinia amylovora is the causative agent of fire blight, a bacterial
disease of apples (Malus sylvestris) and pears (Pyrus communis
L.). Fire blight is a devastating necrotic disease, resulting in serious
economic losses to the apple and pear industry. In the USA alone,
average regional losses and cost of fire blight control reach over
$100 million annually (Norelli et al., 2003). Since the 1970s, streptomycin applications during bloom time in spring have been the
most effective in controlling blossom blight. However, the occurrence of streptomycin-resistant E. amylovora strains in Washington, New York, Oregon, Missouri, Michigan, Canada and elsewhere
has rendered this antibiotic ineffective (Coyier and Covey, 1975;
Loper et al., 1991; Manulis et al., 1998; McGhee and Sundin,
2011; Norelli et al., 2003; Russo et al., 2008; Shaffer and
Goodman, 1985). Thus, alternative new strategies for the control
of fire blight are needed to prevent severe losses in susceptible
orchards (Kim et al., 2012).
The discovery of the hypersensitive response (HR) and pathogenicity (hrp) gene cluster, which encodes a type III secretion
system (T3SS) common to Gram-negative bacterial pathogens, is
a breakthrough discovery in modern molecular plant bacteriology (He et al., 2004). Like many other Gram-negative plantpathogenic bacteria, E. amylovora also contains an hrp-T3SS that
delivers effector proteins into host plants (Oh and Beer, 2005; Oh
et al., 2005). In E. amylovora, the T3SS is required to elicit an HR
on nonhost plants and to cause disease on susceptible host
plants. The hrp gene cluster of E. amylovora is located within
∼60 kb of pathogenicity island 1 (PAI-1) that includes T3SS regulatory genes (hrpL, hrpS and hrpXY), genes encoding structural
components of T3SS and effectors (Oh and Beer, 2005; Oh et al.,
2005; Zhao and Qi, 2011). Based on current knowledge,
E. amylovora T3SS secretes at least 15 virulence-associated proteins, including HrpA, HrpN, HrpW, HrpJ, HrpK, HopAK1 (Eop2),
DspE, HopC1, HopX1 (Eop3), AvrRpt2 (Eop4) and Eop1 (EopB)
(Bogdanove et al., 1998; Nissinen et al., 2007; Zhao et al., 2005,
2006).
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Thus far, two pathogenicity factors, including T3SS and its effectors and the acidic exopolysaccharide (EPS) amylovoran, are
required for E. amylovora to cause disease (Zhao and Qi, 2011;
Zhao et al., 2009a). Amylovoran biosynthetic genes are located
within a 12-gene amylovoran biosynthetic (ams) operon, designated as amsA to amsL, with amsG as the first gene in the operon
(Bernhard et al., 1993; Bugert and Geider, 1995). Two genes adjacent to the ams cluster, galE and galF, and located on the right are
involved in amylovoran precursor formation. Amylovoran
biosynthesis is strictly regulated by the Rcs phosphorelay system,
which is also required for virulence (Wang et al., 2009, 2012; Zhao
et al., 2009b). Additional determinants contribute to virulence and
plant colonization of E. amylovora, including the extracellular EPS
levan, protease, iron-scavenging siderophore desferrioxamine and
genes involved in sorbitol and sucrose metabolism (Aldridge et al.,
1997; Bogs and Geider, 2000; Dellagi et al., 1998, 1999; Du and
Geider, 2002; Khan et al., 2012; Zhao and Qi, 2011; Zhao et al.,
2009b).
As a member of the family Enterobacteriaceae, E. amylovora is
closely related to many mammalian pathogens, including
Escherichia coli, Salmonella enterica, Shigella flexneri and Yersinia
pestis, which also utilize T3SS to deliver effector proteins into their
eukaryotic hosts (Büttner and He, 2009; He et al., 2004). The
T3SS-homologous macromolecular apparatus has been identified
only in Gram-negative bacteria and is a key virulence determinant,
and many studies have conducted chemical screenings by targeting known T3SS processes, including gene expression, effector
secretion and translocation, and symptom development (Baron,
2010; Keyser et al., 2008; Kline et al., 2011). This is based on the
speculation that T3SS is a logical target for chemotherapeutic
intervention, and disabling or blocking the function of T3SS could
serve as a strategy for the control of bacterial diseases. These
large-scale chemical screening studies have led to the discovery
of several classes of T3SS-inhibiting compounds, including
salicylidene acylhydrazides (Baron, 2010; Keyser et al., 2008; Kline
et al., 2011). Subsequent studies have shown that salicylidene
acylhydrazide family compounds broadly interfere with the functionality of T3SS in different mammalian pathogenic bacteria,
including Yersinia pseudotuberculosis, S. enterica, Escherichia coli
O157: H7, enteropathogenic Escherichia coli (EPEC), Shigella
flexneri, Pseudomonas aeruginosa and Chlamydia spp. (Bailey
et al., 2007; Hudson et al., 2007; Kauppi et al., 2003; Layton et al.,
2010; Muschiol et al., 2006, 2009; Negrea et al., 2007; Nordfelth
et al., 2005; Tree et al., 2009; Veenendaal et al., 2009; Wolf et al.,
2006). Furthermore, salicylidene acylhydrazides protect mice from
vaginal infection by Chlamydia trachomatis and Neisseria
gonorrhoeae (Chu et al., 2010; Slepenkin et al., 2011).
Other classes of small-molecule inhibitors of T3SS have also
been reported (Felise et al., 2008; Kimura et al., 2011; Kline et al.,
2009; Pan et al., 2009). Tethered thiazolidinone blocked T3SS
protein secretion of Salmonella typhimurium and Yersinia

enterocolitica, and also prevented HR when Pseudomonas
syringae was co-infiltrated into tobacco (Felise et al., 2008; Kline
et al., 2009). Aurodox, a linear polyketide compound isolated from
Streptomyces sp. K01-0509, has been reported recently to inhibit
the protein secretion of Citrobacter rodentium (Kimura et al.,
2011). The oral administration of aurodox contributed to the survival of mice that had received a lethal dose of C. rodentium.
However, it was unclear whether or not these small-molecule
inhibitors were also effective against plant-pathogenic
enterobacteria, such as E. amylovora.
One of the goals of this study was to determine whether or not
small-molecule inhibitors, such as salicylidene acylhydrazides,
were effective in inhibiting T3SS gene expression in E. amylovora.
Moreover, the global effects of salicylidene acylhydrazide compounds on the transcriptomic profiles of E. amylovora were evaluated. Finally, the efficacy of these compounds in controlling fire
blight by either disabling or blocking of T3SS function during
blossom infection was also investigated.

RESULTS
Screening of small-molecule inhibitors that suppress
T3SS gene expression in vitro
To define in vitro growth conditions that induce T3SS gene expression in E. amylovora, two media [hrp-inducing minimal medium
(HMM) and M9] amended with different carbon sources, including
galactose, glucose, mannitol and fructose, each at 10 and 20 mM,
were used. The promoter activities of T3SS genes were determined
by flow cytometry (Wang et al., 2009). HMM containing 20 mM
galactose elicited the strongest inducing effect on T3SS gene
promoter activities (data not shown; Fig. S1A, see Supporting
Information) (Gaudriault et al., 1997). Moreover, following a timecourse study of hrp gene promoter activities in HMM containing
20 mM galactose, the expression of hrpL, hrpN, dspE and hrpA
genes increased with time and reached their highest levels at 18 h
(Fig. S1B). Thus, HMM containing 20 mM galactose was selected
as the medium of choice, and bacteria were grown for 18 h at
18 °C in all subsequent chemical screening experiments.
Fifteen small-molecule inhibitors were selected and tested for
the suppression of the promoter activities of hrpN, dspE, hrpA and
hrpL genes in E. amylovora. These compounds were selected as
either they have been reported to inhibit T3SS gene expression in
related enterobacterial pathogens (Felise et al., 2008; Pan et al.,
2009; Tree et al., 2009) or they shared similar structures with T3SS
inhibitor compounds (chemical compounds 9–12). Based on their
abilities to inhibit the promoter activities of the four target T3SS
genes, these compounds were divided into three groups. Chemical
compounds 1, 2, 3 and 9 strongly inhibited the promoter activities
of hrpN, dspE, hrpA and hrpL genes (Fig. 1). However, chemical
compounds 4, 12, 14 and 16 had low to modest inhibitory effects
MOLECULAR PLANT PATHOLOGY © 2013 BSPP AND JOHN WILEY & SONS LTD
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Fig. 1 Effect of small-molecule inhibitors on the promoter activities of hrpN, dspE, hrpL and hrpA genes in Erwinia amylovora strain Ea273. Bacterial strains were
grown in hrp (hypersensitive response and pathogenicity)-inducing minimal medium (HMM) in the presence of 100 μM of the corresponding compounds at 18 °C
for 18 h. The equivalent volume of dimethylsulphoxide (DMSO) was added as a control. Error bars represent the standard deviation. One-way analysis of variance
(ANOVA) and Turkey’s W-test (P = 0.05) were carried out to determine the difference in the means using the SAS program.

on the promoter activities of one to four genes, whereas chemical
compounds 5–8, 10, 11 and 15 had either minimal or no inhibitory
effects on the promoter activities of these T3SS genes (Fig. 1).
Thus, for the remainder of this study, experiments were conducted
using chemical compounds 3 and 9, as compound 3 is the most
potent in suppressing T3SS gene expression and compound 9 has
not been reported previously.
Both chemical compounds 3 and 9 exhibited similar inhibitory
effects on the promoter activities of the four target T3SS genes at
different concentrations (Fig. S2, see Supporting Information). To
eliminate the likelihood that these compounds resulted in growth
defects of E. amylovora, bacterial growth was monitored in vitro
in the presence of these two compounds under hrp-inducing conditions, and no significant effects on E. amylovora growth were
observed (Fig. S3A, see Supporting Information).
Effects of chemical compounds 3 and 9 on the
transcriptome of E. amylovora
Microarray analysis was used to evaluate the transcriptomic profiles of E. amylovora following the treatment of bacterial cultures
with compounds 3 and 9 relative to dimethylsulphoxide (DMSO),
© 2013 BSPP AND JOHN WILEY & SONS LTD MOLECULAR PLANT PATHOLOGY

all grown in HMM containing 20 mM galactose (Fig. 2). A total of
588 genes were significantly differentially expressed, of which 320
and 268 genes were suppressed or induced by the compounds,
respectively (Table S1, see Supporting Information). For treatment
with compound 3, 251 genes were up-regulated and 279 genes
were down-regulated, whereas, for compound 9 treatment, 112
genes were up-regulated and 119 genes were down-regulated
when compared with DMSO treatment (Fig. 2, Table S1). Based on
the combined results from both compounds, 78 genes were commonly suppressed and 95 genes were commonly induced by compounds 3 and 9 (Fig. 2).
Overall, the expression of the majority of the 38 known T3SS
genes was down-regulated or suppressed by compound 3, and
some were suppressed by compound 9, when compared with
DMSO treatment (Table 1). These genes included regulatory genes
(hrpL and hrpS), all known effectors (avrRpt2, hopC1, hopAk1,
hopX1, dspE, eop2 and hrpW), chaperones (dspF, esc1 and esc3)
and T3SS structural genes (Table 1). However, both hrpN and hrpA
hybridization spots on the microarray were saturated, thus resulting in a ratio of 1.0 (Table 1). In addition, compound 3 suppressed
the expression of 14 amylovoran precursor and biosynthesis genes
(galEF and amsABCDEFGHIJKL) (Table 1). All ams genes also
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avrRpt2, amsG, amsD, glgB, foxR and EAM_3350. The results of
qRT-PCR were mostly consistent with those of microarray analysis,
except for hrpN and hrpA, which showed strong inhibition in
qRT-PCR analysis (Fig. 3). The expression of hrpA in qRT-PCR for
compounds 3 and 9 was suppressed by 0.13- and 0.66-fold,
respectively, whereas the expression of hrpN was suppressed by
fold changes of 0.07 and 0.29, respectively.
Other small-molecule inhibitors exhibit similar gene
expression patterns

Fig. 2 Venn diagrams showing the number of differentially expressed genes
in compound 3- and 9-treated samples relative to dimethylsulphoxide
(DMSO) control. Differentially expressed genes were those that were activated
(>twofold) or suppressed (<twofold) by compounds 3 (50 μM) and 9
(50 μM), respectively. Erwinia amylovora strain Ea273 was grown in hrp
(hypersensitive response and pathogenicity)-inducing minimal medium (HMM)
at 18 °C for 18 h.

exhibited lower levels of expression following treatment with
compound 9 when compared with DMSO treatment. These results
indicated that both compounds inhibited T3SS and amylovoran
biosynthesis genes. Furthermore, the membrane-encoding protein
operon (EAM_2938-2935), reported to be positively regulated by
HrpL and RcsBC (McNally et al., 2012; Wang et al., 2012), was
also inhibited by compounds 3 and 9 (Table 1).
Among the up-regulated genes, five glycogen metabolism
genes (glgABCPX) and 13 exogenous iron uptake system genes,
including siderophore desferrioxamine E biosynthesis (dfoJAC),
siderophore-interacting protein (EAM_3350), TonB-dependent
ferrioxamine receptors (foxR, EAM_1726), TonB-dependent receptor complex (tonB, exbBD) and TonB-dependent transporter genes
[haemin ABC transporter (hmuVUTS)], were highly induced by
both compounds (Table 2). In addition, yet another 35 genes were
commonly up-regulated by both compounds, and these encoded
membrane, lipoprotein, exported proteins and oxidative stressrelated proteins and transporters (Table 2). Furthermore, some
iron–sulphur cluster genes (sufAC) were also induced by compound 3 (Table S1), suggesting that this compound might also
interfere with endogenous iron function.
Validation of microarray data by quantitative
real-time polymerase chain reaction (qRT-PCR)
To validate the results of the microarray data, qRT-PCR was carried
out for 10 selected genes, including hrpA, dspE, hrpL, hrpN,

qRT-PCR analysis was also performed to evaluate the influence of
compounds 1, 2 and 4 on the expression levels of selected target
genes, including four hrp genes (hrpA, hrpN, hrpL and dspE), an
amylovoran biosynthesis gene (amsG) and two iron uptake genes
(EAM_359 and hmuS) in E. amylovora. Similar to the results
obtained with compounds 3 and 9, all three compounds, 1, 2 and
4, suppressed both T3SS and ams gene expression, but induced the
expression of iron acquisition genes, when compared with DMSO
treatment (Fig. 4). For example, hrpL expression levels exhibited
fold changes of 0.51, 0.20, 0.24, 0.7 and 0.19 for compounds 1, 2,
3, 4 and 9, respectively. In contrast, expression of the haemin
transport protein-encoding gene hmuS exhibited fold changes of
52.27, 5.09, 50.12, 9.99 and 22.91 for compounds 1, 2, 3, 4 and 9,
respectively. These results suggest that the suppression of either
T3SS or ams expression, together with the induction of iron uptake
gene expression, may represent a common transcriptional effect
of these compounds.
Small-molecule inhibitors suppress
amylovoran production
To determine whether small-molecule inhibitors influence the production of amylovoran, a cetylpyrimidinium chloride (CPC) assay
was performed as described previously (Zhao et al., 2009b). At a
concentration of 25 μM, the optical densities at 600 nm (OD600),
which reflect amylovoran production, were 1.09, 1.09, 0.99, 1.19
and 1.32 for compounds 1, 2, 3, 4 and 9, respectively, when
compared with DMSO (1.40) (Fig. 5). This indicates that all of
these chemical compounds suppress amylovoran production
slightly, although this is not statistically significant for compound
9 relative to DMSO treatment.
Compound 3 delays disease progress on
crab apple flowers
To determine whether small-molecule inhibitors could prevent fire
blight disease development on stigmas, a crab apple flower assay
was carried out as described previously (Pusey, 1997). As chemical
compound 3 is the most potent in suppressing T3SS gene expression, it was selected for this experiment. Six days post-inoculation,
MOLECULAR PLANT PATHOLOGY © 2013 BSPP AND JOHN WILEY & SONS LTD

Inhibitors of type III secretion in E. amylovora

5

Table 1 Suppression of type III secretion system (T3SS) and amylovoran biosynthesis genes after treatment with compounds 3 and 9.
Gene ID

Gene

Compound 3/DMSO*

Compound 9/DMSO*

Protein description

EAM_0423
EAM_2190
EAM_2697
EAM_2780
EAM_2871
EAM_2872
EAM_2873
EAM_2874
EAM-2875
EAM_2876
EAM_2877
EAM_2878
EAM_2879
EAM_2880
EAM_2881
EAM_2882
EAM_2883
EAM_2884
EAM_2885
EAM_2886
EAM_2887
EAM_2891
EAM_2894
EAM_2895
EAM_2896
EAM_2897
EAM_2898
EAM_2899
EAM_2900
EAM_2901
EAM_2902
EAM_2903
EAM_2904
EAM_2905
EAM_2908
EAM_2909
EAM_2910
EAM_2911
EAM_2161
EAM_2162
EAM_2163
EAM_2164
EAM_2165
EAM_2166
EAM_2167
EAM_2168
EAM_2169
EAM_2170
EAM_2171
EAM_2172
EAM_2173
EAM_2174
EAM_2935
EAM_2936
EAM_2937
EAM_2938

avrRpt2(eop4)
hopX1(eop3)
hopC1
hopAK1(eop2)
dspF
dspE
hrpW
esc3(orfC)
eop1(orfB)
esc1(orfA)
hrpN
hrpV
hrpT
hrcC
hrpG
hrpF
hrpE
hrpD
hrcJ
hrpB
hrpA
hrpS
hrpL
hrpJ
hrpI
hrpQ
hrcN
hrpO
hrpP
hrcQ
hrcR
hrcS
hrcT
hrcU
hsvC
hsvB
hsvA
hrpK
galE
galF
amsL
amsK
amsJ
amsF
amsE
amsD
amsC
amsB
amsA
amsI
amsH
amsG

0.27
0.24
0.31
0.23
0.27
0.28
0.37
0.37
0.38
0.26
0.92†
0.21
0.25
0.22
0.28
0.18
0.19
0.17
0.24
0.39
0.77
0.41
0.16
0.19
0.18
0.26
0.21
0.30
0.25
0.18
0.23
0.17
0.32
0.19
0.06
0.04
0.06
0.39
0.42
0.33
0.38
0.26
0.33
0.45
0.26
0.30
0.34
0.28
0.24
0.24
0.28
0.34
0.29
0.15
0.26
0.38

0.38
0.55†
0.41
0.52
0.89†
0.73
0.70†
0.63†
0.62†
0.43
1.04†
0.44
0.54†
0.42
0.56
0.43
0.40
0.32
0.44
0.64
1.11†
0.97†
0.28
0.37
0.37
0.53
0.41
0.47
0.53†
0.48
0.53†
0.44
0.57
0.45
0.35
0.22
0.30
0.47
0.94†
0.77†
0.85†
0.56
0.69†
0.98†
0.65
0.65
0.84†
0.71
0.69†
0.68†
0.72†
0.93†
0.53
0.36
0.5
0.62

Cysteine protease protein AvrRpt2
Type III effector protein HopC1
Putative type III effector protein
Type III effector (pectin lyase)
Putative avirulence protein
Type III effector protein
Putative pectate lyase
Chaperone
Effector protein Eop1
Chaperone for Eop1
Harpin
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Sigma 54 enhancer-binding protein
Sigma factor HrpL
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
Type III secretion system protein
type III secretion system protein
type III secretion system protein
type III secretion system protein
type III secretion system protein
type III secretion system protein
type III secretion system protein
Conserved hypothetical protein
Conserved hypothetical protein
Putative amidinotransferase
Type III secretion system protein
UDP-glucose 4-epimerase
UTP-glucose-1-phosphate uridylyltransferase
Amylovoran biosynthesis protein
Glycosyltransferase
Amylovoran biosynthesis protein
Amylovoran biosynthesis protein
Amylovoran glycosyltransferase
Glycosyltransferase
Oligosaccharide repeat unit polymerase
Glycosyltransferase
Tyrosine-protein kinase
Protein-tyrosine-phosphatase
Amylovoran export protein
UDP-galactose-lipid carrier transferase
γ-Glutamyltranspeptidase
Putative exported protein
Putative disulphide bond formation membrane protein
Putative membrane protein

*Expression ratio ≤0.5 indicates genes were suppressed in compound treatments.
†P > 0.05; all others with P < 0.05.
Bold type indicates that corresponding spots were saturated in the array.
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Table 2 Genes activated by compounds 3 and 9.
Gene ID

Gene

Compound 3/DMSO*

Compound 9/DMSO*

Protein description

EAM_3268
EAM_3269
EAM_3270
EAM_3271
EAM_3272
EAM_0358
EAM_0359
EAM_0360
EAM_0361
EAM_1639
EAM_1640
EAM_1641
EAM_1642
EAM_1726
EAM_1888
EAM_2955
EAM_2956
EAM_3350
EAM_2594
EAM_2595
EAM_2596
EAM_2597
EAM_0425
EAM_0561
EAM_0565
EAM_0611
EAM_0612
EAM_0624
EAM_9625
EAM_0893
EAM_0927
EAM_0965
EAM_0966
EAM_1076
EAM_1077
EAM_1078
EAM_1086
EAM_1190
EAM_1231
EAM_1543
EAM_1544
EAM_1616
EAM_1617
EAM_1958
EAM_1984
EAM_2038
EAM_2057
EAM_2058
EAM_2059
EAM_2467
EAM_2941
EAM_3038
EAM_3377

glgP
glgA
glgC
glgX
glgB
foxR
dfoC
dfoA
dfoJ
hmuV
hmuU
hmuT
hmuS

5.58
6.91
7.18
5.06
7.34
13.17
60.30
236.45
214.85
59.27
64.50
118.68
99.19
32.4
2.92
4.53
6.20
15.4
18.3
15.3
9.1
5.7
3.46
2.15
2.11
3.0
2.11
6.16
5.15
6.86
7.55
10.0
8.43
7.79
3.26
3.45
2.40
17.7
9.74
8.05
9.17
3.40
6.47
4.38
6.84
3.46
5.74
5.96
6.7
4.91
20.2
4.12
5.93

3.32
3.24
4.03
2.43
3.75
7.35
43.63
133.50
120.14
37.76
46.38
73.26
71.24
4.87
4.02
4.44
6.13
22.4
10.5
9.1
5.72
4.72
2.03
2.03
2.0
2.41
2.0
2.65
2.61
2.60
3.65
3.75
3.79
2.69
9.37
12.4
2.34
3.77
5.19
3.62
3.82
2.14
10.6
1.49
2.77
2.04
7.49
7.4
7.98
2.82
19.2
2.03
3.20

Glycogen phosphorylase
Glycogen synthase
Glucose-1-phosphate adenylyltransferase
Glycogen debranching enzyme
1,4-α-Glucan branching enzyme
Ferrioxamine TonB-dependent receptor
Decarboxylase
Siderophore biosynthesis protein
Siderophore biosynthesis
Haemin ABC transporter
Haemin ABC transporter
Haemin ABC transporter
Haemin ABC transporter
TonB-dependent receptor
TonB protein
Biopolymer transport protein
Biopolymer transport protein
Putative siderophore-interacting protein
Glutaredoxin-like protein
Putative flavodoxin
Ribonucleoside-diphosphate reductase 2 α chain
Ribonucleoside-diphosphate reductase 2 β chain
Outer membrane lipoprotein
Putative exported protein
Putative membrane protein
Osmotically inducible protein Y
Putative membrane protein
Putative lipoprotein
Putative polypeptide transport protein
Putative exported protein
Putative membrane protein
Putative lipoprotein
Putative phospholipid-binding protein
Peroxiredoxin (osmotically-inducible protein C)
Putative membrane protein
Putative membrane protein
Putative lipoprotein
Putative exported protein
Putative membrane protein
Putative lipoprotein
Putative exported protein
Osmotically inducible lipoprotein E
Putative membrane protein
Osmotically inducible lipoprotein B
Putative membrane protein
Putative membrane protein
Putative peroxidase
Putative exported protein
Putative permease
Extracellular metalloprotease
Putative ABC transporter
Putative exported protein
Putative exported protein

tonB
exbD
exbB
nrdH
nrdI
nrdE
nrdF
blc

osmY

osmC

osmE
osmB

prt1

*Expression ratio ≥2.0 indicates genes were activated in compound treatments; P < 0.05.

a significant difference in symptom development in pistils was
observed for compound 3-treated flowers relative to treatment
with DMSO alone (Fig. 6). Pistils of flowers inoculated with a dspE
mutant of E. amylovora, which is nonpathogenic, remained
healthy and showed the least amount of necrosis at the inoculation site. Similarly, compound 3-treated flowers exhibited slight

necrotic symptoms. In contrast, flowers inoculated with either the
wild-type (WT) strain alone or the WT strain treated with DMSO
exhibited heavy necrosis along entire pistils (Fig. 6).
To investigate whether compound 3 also affected E. amylovora
growth in vivo, bacterial growth was determined using dilution
plating. Two and four days post-inoculation, bacterial populations
MOLECULAR PLANT PATHOLOGY © 2013 BSPP AND JOHN WILEY & SONS LTD
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Fig. 3 Verification of microarray data by quantitative real-time polymerase
chain reaction (qRT-PCR). The relative fold change of each gene was derived
from the comparison of the compound-treated versus dimethylsulphoxide
(DMSO)-treated Erwinia amylovora strain Ea273 in hrp (hypersensitive
response and pathogenicity)-inducing minimal medium (HMM) for compounds
3 and 9 using qRT-PCR. The 16S rDNA (rrsA) gene was used as a control. The
values of the relative fold change were means of three replicates. The
experiments were repeated three times with similar results. Error bars indicate
the standard deviation.

were found to be comparable between DMSO- and compound
3-treated flowers. By six days post-inoculation, compound
3-treated flowers showed about a two-fold reduction in bacterial
population when compared with those inoculated with WT treated
with DMSO alone, although this difference was not statistically
significant (Fig. S3B).
We also tested whether these compounds could inhibit the
elicitation of HR by E. amylovora in tobacco. Surprisingly, none
of the 15 compounds inhibited HR when infiltrated with
E. amylovora strain Ea273 at levels of 10–100 μM. When
E. amylovora strain Ea1189 was used, at 50 μM or higher, three
compounds (6, 8 and 11) inhibited HR development at 24 h
(Fig. S4, see Supporting Information; data not shown for compound 6); however, normal HR was observed at 48 h for all compounds at all levels.
© 2013 BSPP AND JOHN WILEY & SONS LTD MOLECULAR PLANT PATHOLOGY
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Fig. 4 Effect of salicylidene acylhydrazide inhibitors on virulence gene
expression. Relative fold changes were determined by quantitative real-time
polymerase chain reaction (qRT-PCR) for hrpA, dspE, hrpL, hrpN, amsG,
EAM_359 and hmuS genes. Erwinia amylovora Ea273 was grown in the
presence of compounds 1–4 and 9 (50 μM) in hrp (hypersensitive response
and pathogenicity)-inducing minimal medium (HMM) at 18 °C for 18 h. The
16S rDNA (rrsA) gene was used as a control. The values of the relative fold
change were means of three replicates. The experiments were repeated three
times with similar results. Error bars indicate the standard deviation.

DISCUSSION
As a landmark discovery, advances in the study of bacterial virulence factors have provided mounting evidence that T3SS is a
potent virulence mechanism shared by a broad spectrum of pathogenic Gram-negative bacteria that infect both plant and mammalian hosts (He et al., 2004). Thus, the T3SS apparatus is essential
for bacterial cells to evade host immune defenses, and T3SS could
serve as a universal target for the development of novel antibacterial agents (Baron, 2010; Kline et al., 2011). It is likely that
agents that inhibit T3SS can result in an antibacterial response
without killing bacteria (Keyser et al., 2008). In this study, 15
chemical compounds known to either act or share similar structures to those reported as T3SS inhibitors were evaluated for their
suppression of T3SS gene expression in E. amylovora. Among
these, four compounds were found to either strongly or moderately suppress T3SS gene expression. Two of these compounds
(9 and 12) have not been reported previously to act as T3SS
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Fig. 5 Effect of small-molecule inhibitors on amylovoran production. Erwinia
amylovora strain Ea273 was grown in MBMA medium with 1% sorbitol at
28 °C for 24 h with shaking. Chemical compounds and an equal volume of
dimethylsulphoxide (DMSO) were added to the cell culture at a final
concentration of 25 μM. Amylovoran concentrations were measured by the
cetylpyrimidinium chloride (CPC) method and normalized to a cell density of
unity. Data points represent the means of three replicates ± standard
deviations. Each experiment was performed at least three times with similar
results.

Fig. 6 Virulence assay on crab apple (Malus mandshurica) flowers. Symptoms
of crab apple flowers at 6 days post-inoculation with Erwinia amylovora
strain Ea273, dspE mutant, Ea273 treated with dimethylsulphoxide (DMSO)
or compound 3 at 50 μM. Photographs were taken at 6 days
post-inoculation. The experiments were repeated three times with similar
results. Arrow indicates representative inoculation site (stigma) and symptoms
below on style and ovary.

inhibitors. Moreover, five compounds (5–8 and 15), reported previously to inhibit T3SS in other bacteria, were not found to be
effective against E. amylovora.
High-throughput screening is a powerful tool in the identification of small-molecule inhibitors that disable T3SS function.
Recent studies have identified several classes of synthetic compounds, as well as natural products, as active T3SS inhibitors in a
wide range of Gram-negative bacterial pathogens, including
Escherichia coli, Salmonella, Yersinia, Shigella and Chlamydia
(Baron, 2010; Gauthier et al., 2005; Keyser et al., 2008; Kline
et al., 2011; Muschiol et al., 2006). These inhibitors include
salicylanilides, salicylidene anilides, salicylidene acylhydrazides,
thiazolidinone, sulphonylaminobenzanilides, caminosides and
guadinomines, and are likely to target T3SS gene expression, conserved outer membrane proteins, effector secretion and needle
assembly. Pan et al. (2009) have also described a group of T3SSinhibiting compounds of diverse chemical structures that are distinct from all previously reported T3SS inhibitors.
In this study, all compounds that suppressed the expression of
T3SS genes in E. amylovora under hrp-inducing conditions
belonged to the salicylidene acylhydrazides, except for one compound: 16. This is the largest family of small-molecule inhibitors
identified thus far (Keyser et al., 2008; Wang et al., 2011). Recent
evidence suggests that this group of compounds interferes with
various T3SS functions, including gene expression, effector secretion or translocation, and needle assembly (Kauppi et al., 2003;
Muschiol et al., 2006, 2009; Veenendaal et al., 2009; Wolf et al.,
2006). In this study, the suppression of T3SS gene expression by
compounds 3 and 9 was found to be dose dependent in
E. amylovora, and similar results were observed for all five compounds (1–4 and 9) tested for their effect on gene expression.
Global gene expression profiles for compounds 3 and 9 have
indicated that the transcriptional profiling for E. amylovora is
highly similar to that reported for Escherichia coli O157: H7 and
S. typhimurium after salicylidene acylhydrazide treatment (Layton
et al., 2010; Tree et al., 2009). Previously, it has been demonstrated that salicylidene acylhydrazides suppress the transcription
of all T3SS genes of Escherichia coli O157: H7 and S. typhimurium
(Layton et al., 2010; Tree et al., 2009). In this study, compounds 3
and 9 also exhibited strong inhibition of all known T3SS genes in
E. amylovora. It is important to note that this is the first report of
the T3SS inhibitory effect of compound 9. These findings indicate
that salicylidene acylhydrazides broadly inhibit T3SS gene expression not only in mammalian pathogens, but also in plantpathogenic enterobacteria. Furthermore, this suggests that the
suppression of T3SS by salicylidene acylhydrazide is a conserved
transcriptional response among different bacterial species.
However, other compounds, such as 6, 7 and 8, also inhibit T3SS in
some organisms (Felise et al., 2008, Pan et al., 2009), but are not
effective in E. amylovora, thus suggesting that these compounds
are likely to have specific targets.
MOLECULAR PLANT PATHOLOGY © 2013 BSPP AND JOHN WILEY & SONS LTD
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Amylovoran is another essential pathogenicity factor of
E. amylovora (Zhao et al., 2009a, b). Transcriptomic analysis has
revealed that salicylidene acylhydrazides also inhibit amylovoran
production and amylovoran biosynthesis gene expression, but
promote glycogen gene expression. These findings demonstrate,
for the first time, that salicylidene acylhydrazides may also target
other bacterial virulence factors in addition to T3SS. It has been
reported that salicylanilide class compounds inhibit twocomponent signal transduction systems in bacteria (Macielag
et al., 1998). In E. amylovora, the RcsBCD phosphorelay twocomponent system plays an essential role in controlling
amylovoran and glycogen production, as well as virulence (Wang
et al., 2009, 2012). Therefore, it is likely that salicylidene
acylhydrazides may act on the RcsBCD system as well.
Another unique feature of the salicylidene acylhydrazideinduced transcriptome is the activation of the iron uptake system.
Layton et al. (2010) have observed that about one-quarter of
genes in S. typhimurium regulated significantly following treatment with 100 μM INP0403 (compound 2 in this study) are genes
involved in iron acquisition, including the TonB-dependent receptor complex (tonB, exbBD), ABC ferric transporter (fepABCDEG),
iron transport (feoAB, fhuABCDEF) and iron uptake regulator (fur).
Similarly, in this study, most of the activated genes of the
E. amylovora transcriptome by compounds 3 and 9 were exogenous iron uptake genes, including genes involved in siderophore
desferrioxamine E biosynthesis (dfoJAC), siderophore-interacting
protein (EAM_3350), TonB-dependent ferrioxamine receptors
(foxR, EAM_1726), TonB-dependent receptor complex (tonB,
exbBD), TonB-dependent transporter genes [haemin ABC transporter (hmuVUTS)] and endogenous iron–sulphur assembly genes
(sufAC). These findings further suggest that a common mechanism
may be shared by salicylidene acylhydrazides in regulating bacterial transcription. However, both compounds inhibit the expression
of the ftnA gene (EAM_2940) by more than five-fold (Table S1).
Ferritin, encoded by ftnA, is a primary intracellular iron storage
protein that stores iron and contributes to its controlled release.
Reduced levels of ferritin proteins result in reduced iron storage.
This indicates that iron uptake/release may be fundamental in
protecting bacteria from salicylidene acylhydrazides. As
siderophore desferrioxamine is a virulence factor in E. amylovora
(Dellagi et al., 1998, 1999), this new finding may suggest a unique
role for siderophores in protecting bacteria from stress conditions,
in addition to their role in virulence.
Both compounds 9 and 12 suppressed the expression of a
membrane-encoding protein operon (EAM_2938-2935) (Table 1),
previously reported to be positively regulated by HrpL and RcsBC,
and to be a novel virulence factor (McNally et al., 2012; Wang
et al., 2012). Interestingly, both compounds also activated 35
genes that encode for membrane, lipoprotein, exported proteins,
oxidative stress-related proteins (such as OsmC) and ABC transporters (Table 2). However, the precise role of these membrane
© 2013 BSPP AND JOHN WILEY & SONS LTD MOLECULAR PLANT PATHOLOGY
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and lipoprotein-encoding genes remains unknown. Recently, thiol
peroxidase Tpx and oxidoreductase WrbA have been shown to be
putative targets of salicylidene acylhydrazide compounds, and
conformational changes of Tpx between reduced and oxidized
states affect the binding ability to these compounds (Gabrielsen
et al., 2012; Wang et al., 2011). However, in this study, there were
no observed differences in expression of tpx and other
peroxiredoxin genes, such as ahpC and sodA. However, several
genes encoding redox proteins and central metabolism, such as
fpr (EAM_0114), encoding ferredoxin-NADP reductase, the nuo
operon (nuoABCEFGHIJKLMN), encoding the energy-conserving
NADH dehydrogenase, the succinate dehydrogenase operon
(sdhABCD) and the succinyl-CoA synthetase operon (sucABCD),
are highly suppressed either by both compounds or by compound
3 (Table S1). Recruitment of ‘free’ ferrous iron has been found to
generate destructive hydroxyl radicals through the Fenton reaction. The ferrous iron can also be released from Fe–S clusters when
superoxide production is induced. As Tpx and WrbA are scavengers
of reactive oxygen species (ROS), and alterations in central
metabolism related to NADP consumption are critical for
superoxide-mediated Fe–S cluster destabilization and for the
stimulation of the Fenton reaction (Davies et al., 2009; Dwyer
et al., 2007; Kohanski et al., 2010), it is likely that salicylidene
acylhydrazides may increase iron uptake, which, in turn, promotes
the formation of ROS. Recent studies have also suggested that
ROS can regulate both the structure and function of a variety of
biomolecules by altering their oxidation–reduction (redox) states
(Fang, 2011). Thus, it is tempting to speculate that exposure to
these small molecules could also result in ROS that act as redox
signals, thus disrupting T3SS function and amylovoran
biosynthesis. Future analysis is necessary to fully address the
mode of action of these salicylidene acylhydrazides in inhibiting
T3SS functions.
In the spring, blossom blight infection is the main source of
dissemination of E. amylovora, and the pathogen must establish
large epiphytic populations on stigmas of flowers for further successful infection of host plants. The control of fire blight is
achieved mainly following the application of antibiotics to flowers
to suppress pathogen infection. Using crab apple flowers as a
model, we have shown that compound 3 is capable of reducing
disease development in pistils. These results suggest that smallmolecule inhibitors that disable T3SS function could be useful in
the control of fire blight disease.

EXPERIMENTAL PROCEDURES
Bacterial strains and growth media
The bacterial strains and plasmids used in this study are listed in Table 3.
Luria–Bertani (LB) medium was routinely used for the culture of
E. amylovora. Amylovoran production was determined by growing bacte-
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Table 3 Bacterial strains, plasmids and small-molecule inhibitors used in this study.
Strain or plasmid
Erwinia amylovora
Ea273
Ea1189
Ea273a
ΔdspE
Plasmids
pFPV25
pHrpN-GFP
pHrpA-GFP
pZW2
pZW3
Small-molecule inhibitors
Compound 1
Compound 2
Compound 3
Compound 4
Compound 5
Compound 6
Compound 7
Compound 8
Compound 9
Compound 10
Compound 11
Compound 12
Compound 14
Compound 15
Compound 16

Relevant characteristics

Reference or source

Wild-type, isolated from apple
Wild-type, isolated from apple
Rifampicin-resistant derivative of Ea273, RifR
dspE::Km; KmR-insertional mutant of dspE of Ea1189, KmR

Wang et al. (2010)
Burse et al. (2004)
This study
Zhao et al., 2009b

ApR, GFP-based promoter trap vector containing a promoterless gfpmut3a gene
735-bp EcoRI-BamHI DNA fragment containing promoter sequence of hrpN gene in pFPV25
708-bp EcoRI-BamHI DNA fragment containing promoter sequence of hrpA gene in pFPV25
608-bp KpnI-XbaI DNA fragment containing promoter sequence of hrpL gene of Ea273 in pFPV25
570-bp SmaI DNA fragment containing promoter sequence of dspE gene of Ea273 in pFPV25 in
forward orientation

Valdivia and Falkow (1997)
This study
This study
Wang et al. (2010)
Wang et al. (2010)

ME0052, INP0010
ME0053, INP0403
ME0054, INP0401
ME0055, INP0031
INP0002
Compound 1, TTS29
Compound 2, CAS #3530-35-6
Compound 3, CAS #27885-92-3
5277768
5472847
5551447
5569869
INP0007
Compound 1, CAS #329057-04-7
Compound 3-didiproprionate, CAS #55750-06-6

Nordfelth et al. (2005)
Nordfelth et al. (2005)
Nordfelth et al. (2005)
Nordfelth et al. (2005)
Negrea et al. (2007)
Felise et al. (2008)
Pan et al. (2009)
Pan et al. (2009)
This study
This study
This study
This study
Negrea et al. (2007)
Pan et al. (2009)
Pan et al. (2009)

ApR, ampicillin resistance; CAS, Chemical Abstracts Service; GFP, green fluorescent protein; KmR, kanamycin resistance; RifR, rifampicin resistance. Compounds 9–12 are
from ChemBridge and have unique numbers.

rial cells in MBMA medium (3 g KH2PO4, 7 g K2HPO4, 1 g [NH4]2SO4, 2 mL
glycerol, 0.5 g citric acid and 0.03 g MgSO4) amended with 1% sorbitol
(Zhao et al., 2009b). Bacterial strains were also grown in HMM (1 g
[NH4]2SO4, 0.346 g MgCl2.6H2O, 0.099 g NaCl, 8.708 g K2HPO4 and 6.804 g
KH2PO4) or M9 minimal medium (12.8 g Na2HPO4.7H2O, 3.0 g KH2PO4,
0.5 g NaCl, 1 g NH4Cl, 0.24 g MgSO4 and 0.011 g CaCl2) to activate T3SS
gene expression by the addition of carbon sources as indicated. When
necessary, the following antibiotics were added to the medium: 50 μg/mL
kanamycin (Km), 100 μg/mL ampicillin (Ap) and 50 μg/mL rifampicin
(Rif).

Small-molecule inhibitors and sources
Chemical compounds 1–4 (Nordfelth et al., 2005), previously reported to
inhibit T3SS of enterobacterial pathogens, were prepared according to
published procedures (Dahlgren et al., 2010), and kindly supplied by Dr
Mikael Elofsson (Fig. S5, see Supporting Information, Table 3). Previously,
other names used for these compounds included ME0052–ME0054 and
INP0010, INP0403, INP0401 and INP0031, respectively (Negrea et al.,
2007; Tree et al., 2009; Veenendaal et al., 2009). Compounds 5–16 were
purchased from ChemBridge (San Diego, CA, USA), Timtec (Newark, DE,
USA) and Sigma-Aldrich (St. Louis, MO, USA) (Fig. S5). Compounds 5 and
14 were also known as INP0002 and INP0007, respectively (Negrea et al.,
2007). Compound 6 was reported by Felise et al. (2008), and compounds
7, 8, 15 and 16 were reported by Pan et al. (2009) to inhibit T3SS, but

referred to as compounds #2, 3, 1 and #3-diproprionate, respectively
(Table 3).

Construction of promoter–green fluorescent protein
(GFP) fusions for promoter activity assays
The promoter region of hrpN and hrpA genes was amplified by PCR. Primer
pairs hrpN1–hrpN2 and hrpA1–hrpA2, with restriction sites, were used to
amplify 735 and 708 bp for hrpN and hrpA promoter sequences from
E. amylovora strain, respectively (Table S2, see Supporting Information).
PCR products and the promoter trapping vector pFPV25 were both
digested with EcoRI and BamHI. The resulting fragments were gel purified,
ligated together and cloned upstream of the promoterless GFP gene. The
final plasmids were designated as pHrpN-GFP for hrpN and pHrpA-GFP
for hrpA, which were confirmed by restriction enzyme digestion and
sequencing.

GFP reporter assays by flow cytometry
The BD FACSCanto flow cytometer (BD Bioscience, San Jose, CA, USA) was
used to monitor the GFP intensities of bacterial strains containing the
corresponding promoter–GFP constructs as described previously (Wang
et al., 2009). For hrp-inducing condition assays, E. amylovora strain Ea273,
containing GFP–promoter fusion plasmids, was grown overnight in LB
medium, and washed twice with phosphate-buffered saline (PBS). The
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bacterial suspension was re-inoculated into either HMM or M9 minimal
medium amended with different carbon sources at different levels. Bacterial cultures were harvested by centrifugation at different time points, and
resuspended in PBS for flow cytometry.
For chemical screening, bacterial strains containing GFP–promoter
fusion plasmids were washed with PBS and resuspended in HMM containing 20 mM galactose. One milliliter of cell suspension was seeded into
24-well plates at a density of OD600 = 0.2. Compounds were added to each
well to yield final concentrations of 10, 25, 50 and 100 μM, and DMSO was
added as a control. GFP intensities were measured by flow cytometry after
incubation at 18 °C for 18 h.
Flow cytometry was performed on a BD LSRII 10 parameter multilaser
analyzer (BD Bioscience). Data were collected for a total of 100 000 events
and analysed statistically by gating using flow cytometry software FCS
Express V3 (De Novo Software, Los Angeles, CA, USA). A geometric mean
was calculated for each sample. Each treatment was performed in triplicate and each experiment was repeated three times.

CPC assays for the determination of
amylovoran concentrations
The amylovoran concentration in supernatants of bacterial cultures was
determined quantitatively using a turbidity assay with CPC, as described
previously (Bellemann et al., 1994; Wang et al., 2009; Zhao et al., 2009b).
Briefly, wild-type E. amylovora Ea273 was grown overnight in LB broth
and washed with PBS three times. After the final wash, the bacterial pellet
was resuspended in 200 μL of PBS. A total of 100 μL of bacterial cells was
inoculated into 10 mL of MBMA medium with 1% sorbitol. A 3-mL cell
suspension was seeded in Falcon tubes. Chemicals were added to the
bacterial suspension to a final concentration of 25 μM, and DMSO was
added as a control. After incubation for 24 h at 28 °C with shaking, 50 μL
of CPC at 50 mg/mL was added to 1 mL of supernatant following centrifugation. After 10 min of incubation at room temperature, the amylovoran
concentration was determined by measuring OD600 turbidity. The final
concentration of amylovoran production was normalized for a cell density
of 1.0. Each treatment was performed in triplicate and each experiment
was repeated three times.

Crab apple flower assays
Bacterial suspensions were grown overnight in LB broth, harvested by
centrifugation and resuspended in PBS at a density of OD600 = 0.2. Bacterial suspensions were incubated with compounds at 50 μM or an equivalent volume of DMSO for 4 h at room temperature in the dark. One-day-old
fully opened crab apple (Malus mandshurica) flowers were detached and
immediately transferred to a microcentrifuge tube containing 2 mL of 10%
sucrose as described previously (Pusey, 1997). Two microlitres of bacterial
suspension were evenly delivered to the stigmas per flower by pipette
under a microscope. The inoculated flowers were held in a sealed container that was incubated in a growth chamber at 24 °C and 90% relative
humidity. Symptoms were recorded at 6 days post-inoculation. For the
bacterial population assays, flowers were homogenized at 0, 2, 4 and
6 days post-inoculation. Populations were estimated by plating serial dilutions and calculating colony-forming units (CFU). Each treatment was
performed in triplicate and each experiment was repeated three times.
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RNA isolation
WT E. amylovora strain Ea273 was grown overnight in LB broth at 28 °C.
Bacterial cells were washed and re-inoculated into HMM after washing
twice with PBS. Two millilitres of cell suspension were seeded into 12-well
tissue culture plates at a density of OD600 = 0.3 cells/well. Compounds
were added to each well at a final concentration of 50 μM, and an equal
volume of DMSO was used as a control. The plates were incubated at
18 °C for 18 h with shaking. The 1.5-mL cultures were stabilized using
3 mL of RNA protect reagent (Qiagen, Hilden, Germany). Cells were harvested by centrifugation for 10 min at 4000 g, and RNA was extracted
using a Qiagen Bacterial RNA Protect Mini Kit as recommended by
the manufacturer (Qiagen). On-column DNA digestion was performed
using Qiagen DNase. RNA was quantified using a NanoDrop ND-100
spectrophotometer (NanoDrop Technologies; Wilmington, DE, USA) and
RNA quality was checked using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA, USA).

Microarray hybridization and data analysis
Microarray hybridization and data analysis were carried out as described
previously (McNally et al., 2012; Wang et al., 2012). Briefly, a 60-mer
E. amylovora microarray (8 × 15 K) was designed at the James Hutton
Institute, Aberdeen, UK and synthesized by Agilent Technologies. Each
slide contains eight arrays, and each array contains ∼15 000 spots, with
each probe spotted in triplicate. A detailed description and design of the
oligonucleotide microarray is available at the ArrayExpress website
(accessions: microarray A-MEXP-2000). All microarray data are available
at the National Center for Biotechnology Information (NCBI) Gene
Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo, accession
number GSE45602). Four biological replicates for each chemical treatment (two samples were combined) were hybridized to three arrays.
Four biological replicates (two each combined) for DMSO treatment
were hybridized to two arrays. All arrays were cross-compared as technical replicates.
Synthesis and labelling of cDNA were performed using a total of
10 μg of total RNA and a FairPlay III microarray labelling kit (Stratagene,
La Jolla, CA, USA) according to the manufacturer’s instructions. After
labelling, the concentration of cDNA was determined by a NanoDrop
ND-100 spectrophotometer. The labelled cDNA (600 ng) was then hybridized to the slide for 17 h at 65 °C in an Agilent rotating oven (10 rpm)
in the presence of a 2 × hybridization buffer (Agilent Technologies). After
successive washing by gene expression wash buffers (Agilent Technologies), the hybridized slide was scanned using an Axon 4000B array
scanner at a resolution of 5 μm (Molecular Devices, Sunnyvale, CA,
USA). Microarray images were processed by GenePix Pro 6.0 image
analysis software (vs. 6.0.1.26, Molecular Devices). Raw data were processed through logarithmic transformation and normalization using R
software (R.2.2.1). Statistical comparisons were performed using multiple testing procedures to evaluate the statistical significance of differentially expressed genes. A modified t-test was computed to measure
the significance associated with each differential expression value. A
gene expression value was assumed to be significantly different when
the P value was less than 0.05 (except otherwise mentioned) and the
expression ratio was ≥2.0 or ≤0.5.
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qRT-PCR
To validate the microarray results, gene expression levels of hrpA, dspE,
hrpL, hrpN, avrRpt2, amsG, amsD, glgB, foxR (EAM_0358), hmuS, dfoJ
(EAM_359) and EAM_3350 were determined by qRT-PCR. For each
sample, synthesis of cDNA was performed using 1 μg of total RNA and
SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA).
Primers were designed using Primer3 software with high specificity and
are listed in Table S2. qRT-PCR was conducted in an ABI 7300 System
(Applied Biosystems, Foster City, CA, USA) using Fast SYBR Green PCR
master mix (Applied Biosystems). All reactions were run on 96-well optical
reaction plates. Thermal cycling conditions included a step of 2 min at
50 °C and 10 min at 95 °C, followed by 40 cycles of 95 °C for 15 s and
60 °C for 1 min, and a final dissociation curve analysis step from 65 °C to
95 °C. Technical replicate experiments were performed for each biological
triplicate sample. The amplification specificity for each reaction was confirmed by dissociation curve analysis. The Ct values determined were then
exploited for further analysis. The relative quantification method (ΔΔCt
method) was used to determine the expression level of selected genes. The
expression of the 16S rRNA gene was used to normalize gene expression
across samples. The gene expression values obtained from DMSO-treated
samples were used to calculate a relative quantification (RQ) value for
each gene (Wang et al., 2012).
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Fig. S1 Promoter activities of type III secretion system (T3SS)
genes of Erwinia amylovora in M9 and hrp (hypersensitive
response and pathogenicity)-inducing minimal medium (HMM)
with different concentrations of carbon sources. (A) Promoter
activities of hrpN, dspE, hrpL and hrpA in E. amylovora strain
Ea273 in M9 and HMM containing 10 and 20 mM of galactose at
18 °C for 18 h. (B) Time course of promoter activities of hrpN,
dspE, hrpL and hrpA in E. amylovora strain Ea273 in HMM containing 20 mM galactose at 18 °C.
Fig. S2 Effect of different concentrations of small-molecule
inhibitors 3 and 9 on promoter activities of hrpN, dspE, hrpL and
hrpA genes. Erwinia amylovora strain Ea273 was grown in hrp
(hypersensitive response and pathogenicity)-inducing minimal
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medium (HMM) at 18 °C for 18 h. The highest volume of
dimethylsulphoxide (DMSO) added (equivalent to 100 μM of
chemicals) is shown as the control.
Fig. S3 (A) Effect of small molecules 3 and 9 on bacterial growth
in hrp (hypersensitive response and pathogenicity)-inducing
minimal medium (HMM) containing 20 mM galactose at 18 °C. (B)
Effect of small molecule 3 on bacterial growth on flowers. Flowers
were homogenized at 0, 2, 4 and 6 days post-inoculation. The
population was measured by plating serial dilutions and calculating colony-forming units (CFU).
Fig. S4 Small-molecule inhibitors delayed the hypersensitive
response (HR) in tobacco. Tobacco leaf was infiltrated with Erwinia

amylovora Ea1189 (OD600 = 0.15) in the presence of compounds 8
(left) and 11 (right) at the different concentrations indicated. The
same volume of dimethylsulphoxide (DMSO) was added as a
control as 100 μM of compounds. Photographs were taken 24 h
post infiltration.
Fig. S5 Structures of the small-molecule inhibitors used in this
study. Not shown are compounds 6 (see Felise et al., 2008; compound #1, TTS29), 7, 8, 15 and 16 (see Pan et al., 2009; compounds #2, 1, 3 and 3-diproprionate, respectively).
Table S1 Differentially expressed genes in all comparisons.
Table S2 Promoter cloning and quantitative real-time polymerase
chain reaction (qRT-PCR) primers used in this study.
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Supplementary Table S2. Promoter cloning and qRT-PCR primers used in this study
Primers

2
3
4

Sequence (5’—3’)

Promoter cloning
hrpN1
CCGGAATTCAAAGCGCTTCCTGTTTACTGC (EcoRI)
hrpN2
CGCGGATCCGCTCCCAGCCCACTTGTAT (BamHI)
hrpA1
CCGGAATTCGTGAAAACGTCAGGCAGCTA (EcoRI)
hrpA2
CGCGGATCCCCTGTAATAATGCCGCTCAT (BamHI)
qRT-PCR
amsD1
GATGCGTCTGTTCAAGCTGT
amsD2
TCGCAACAAATCAGTCTGGA
amsG1
CAAAGAGGTGCTGGAAGAGG
amsG2
GTTCCATAGTTGCGGCAGTT
avrRpt2_1
AAACCTTGCCGAAGTGAGTT
avrRpt2_2
TTGCCAACCAAACATAATGG
dspE1
TCCAGCGAGGGCATAATACT
dspE2
ACAACCGTACCCTGCAAAAC
EAM_359_1
GCACGATCTGGTGTTTATGC
EAM_359_2
AATTTCTTCGCCGATGTCTT
EAM_3350_1
ATCTCAGCCATTACCGCTTT
EAM_3350_2
GCATACTGTTTCACCGCATT
foxR1
CTTCGTGCCTATCTGCAAAA
foxR2
AAACCGGTGCTCAGTTTTCT
glgB1
GGGTTCAATTCTCGACCGTA
glgB2
GGTGTCGTGGTTCCACTCTT
hmuS1
TACAGCAGCAGGGTAACGAG
hmuS2
TGTTCAGCCAGTTGTCCTTC
hrpA1
GAGTCCATTTTGCCATCCAG
hrpA2
TGGCAGGCAGTTCACTTACA
hrpN1
GCTTTTGCCCATGATTTGTC
hrpN2
CAACCCGTTCTTTCGTCAAT
hrpL1
TTAAGGCAATGCCAAACACC
hrpL2
GACGCGTGCATCATTTTATT
16S3
CCTCCAAGTCGACATCGTTT
16S4
TGTAGCGGTGAAATGCGTAG
Underlined nucleotides are restriction sites added and the restriction enzymes are indicated at the end of
primer.
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